Home » Authors » Mark McCarty

Articles by Mark McCarty

Cost containment a central issue in state health plans

Dec. 26, 2006

By Mark McCarty

Carotid stent seen as effective with inexperienced surgeons

Dec. 22, 2006

By Mark McCarty

Drum-beat of battle continues in effort to block imaging cuts

Dec. 21, 2006

By Mark McCarty

CorCap panel outcome hints at tightening of clinical trial rules

Dec. 20, 2006

By Mark McCarty

Too little data for RESUS III as consent trial seen as onerous

Dec. 19, 2006

By Mark McCarty

Hemopure advocates say lives saved, opponents focus on SAEs

Dec. 18, 2006

By Mark McCarty

Drum-beat of battle continues in effort to block imaging cuts

Dec. 14, 2006

By Mark McCarty

Radiology scanning fails to win roll-back of payment reductions

Dec. 14, 2006

By Mark McCarty

Radiology scanning fails to win roll-back of payment reductions

Dec. 13, 2006

By Mark McCarty

Off-label use of DES doesn’t alter panel recommendations

Dec. 12, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 9, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...